The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Energy metabolism in ALS: an underappreciated opportunity?
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disorder that primarily affects motor neurons. Despite our increased understanding of the genetic factors contributing to ALS, no effective treatment is available. A growing body of evidence shows disturbances in energy metabolism in ALS. Moreover, the remarkable vulnerability of motor neurons to ATP depletion has become increasingly clear. Here, we review metabolic alterations present in ALS patients and models, discuss the selective vulnerability of motor neurons to energetic stress, and provide an overview of tested and emerging metabolic approaches to treat ALS. We believe that a further understanding of the metabolic biology of ALS can lead to the identification of novel therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Miro1 deficiency in amyotrophic lateral sclerosis
Zhang, F., Wang, W., Siedlak, S. L., Liu, Y., Liu, J., Jiang, K., Perry, G. L., Zhu, X., & Wang, X. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00100 · Cited by 65
A unique array of neuroprotective effects of pyruvate in neuropathology
Zilberter, Y., Gubkina, O., & Ivanov, A. I. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00017 · Cited by 64 · cited 1×
“The neuroprotective properties of pyruvate are multifaceted and originate from anti-oxidant properties, the ability to facilitate glutamate efflux from the brain, anti-inflammatory effects, and their ability to increase TCA cycling [223].”
BackgroundCurrent technical approaches to brain energy metabolism
Barros, L. F., Bolaños, J. P., Bonvento, G., Bouzier‐Sore, A., Brown, A. M., Hirrlinger, J., Kasparov, S., Kirchhoff, F., Murphy, A. N., Pellerin, L., et al. (2017) · Glia · doi:10.1002/glia.23248 · Cited by 63
ONOFRJ, M. C., Ciccocioppo, F., Varanese, S., Muzio, A. D., Calvani, M., Chiechio, S., Osio, M., & Thomas, A. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.814930 · Cited by 61
Tefera, T. W., Wong, Y., Barkl‐Luke, M. E., Ngo, S. T., Thomas, N. K., McDonald, T. S., & Borges, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161816 · Cited by 61
Sherman, M. S., Pillai, A., Jackson, A. M., & Heiman-Patterson, T. D. (2004) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607104028006442 · Cited by 58
Axonal Mitochondrial Clusters Containing Mutant SOD1 in Transgenic Models of ALS
Sotelo-Silveira, J. R., Lepanto, P., Elizondo, V., Horjales, S., Palacios, F., Palma, L. M., Marı́n, M., Beckman, J. S., & Barbeito, L. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2614 · Cited by 56
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency
Alavian, K. N., Dworetzky, S. I., Bonanni, L., Zhang, P., Sacchetti, S., Mariggiò, M. A., ONOFRJ, M. C., Thomas, A., Li, H., Mangold, J. E., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.046 · Cited by 56
Bayer, H., Lang, K., Buck, E., Higelin, J., Barteczko, L., Pasquarelli, N., Sprissler, J., Lucas, T., Holzmann, K., Demestre, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.11.001 · Cited by 54
Nagel, G., Peter, R. S., Rosenbohm, A., Köenig, W., Dupuis, L., Rothenbacher, D., & Ludolph, A. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-04706-5 · Cited by 54
Chronic Riluzole Treatment Increases Glucose Metabolism in Rat Prefrontal Cortex and Hippocampus
Chowdhury, G. M. I., Banasr, M., de Graaf, R. A., Rothman, D. L., Behar, K. L., & Sanacora, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.78 · Cited by 49
Metabolic correction by pyruvate halts acquired epilepsy in multiple rodent models
Popova, I. Y., Malkov, A., Ivanov, A., Samokhina, E., Buldakova, S., Gubkina, O., Osypov, A. A., Muhammadiev, R. S., Zilberter, T., Molchanov, M. V., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.012 · Cited by 41
Boero, J., Qin, W., Cheng, J., Woolsey, T. A., Strauss, A. W., & Khuchua, Z. A. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022409101641 · Cited by 37
Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model
Park, J., Hong, Y., Kim, H., Kim, S., Kim, M.-J., Park, K. S., Sung, J., & Lee, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.058 · Cited by 32
Daniel, B., Green, O., Viskind, O., & Gruzman, A. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.808226 · Cited by 29
Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration
Vieira, F. G., LaDow, E., Moreno, A. J., Kidd, J. D., Levine, B. A., Thompson, K., Gill, A., Finkbeiner, S. M., & Perrin, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091608 · Cited by 25
Esposito, E., Capasso, M., Tomasso, N. N. D., Corona, C., Pellegrini, F., Uncini, A., Vitaglione, P., Fogliano, V., Piantelli, M., & Sensi, S. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.095 · Cited by 22
Stevens, P., Gawryluk, J. W., Hui, L., Chen, X., & Geiger, J. D. (2015) · Current HIV Research · doi:10.2174/1570162x13666150121101544 · Cited by 22
Neurons eat glutamate to stay alive
Fendt, S., & Verstreken, P. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702003 · Cited by 21
Pramipexole in restless legs syndrome
Manconi, M., Casetta, I., Govoni, V., Cesnik, E., Ferini‐Strambi, L., & Granieri, E. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0244-8 · Cited by 17
Doshi, S., Gupta, P., & Kalb, R. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-13304-4 · Cited by 5
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Langhans, W., Berthoud, H. R., & Westerterp‐Plantenga, M. S. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.245 · Cited by 2
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 302
Lipid droplets in neurodegenerative disorders
Farmer, B. C., Walsh, A. E., Kluemper, J. C., & Johnson, L. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00742 · Cited by 270
Metadata
- Authors
- Vandoorne, T., De Bock, K., & Van Den Bosch, L.
- Venue
- Acta Neuropathologica
- Published
- 2018-03-16
- Volume
- 135
- Issue
- 4
- Pages
- 489-509
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2792402131
- Cited by
- 262
- References
- 223
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.